Teva Posts $452 Million Loss for Second Quarter

Settlement of patent infringement lawsuit with Pfizer drags down what was an otherwise profitable quarter with company revenue of $4.92 billion falling just shy of analysts' forecasts.

Send in e-mailSend in e-mail

Comments